Pietzsch, Jan B.
Geisler, Benjamin P.
Iken, Annabelle R.
van Wijck, Iris P. S.
Holewijn, Suzanne
Reijnen, Michel M. P. J.
Funding for this research was provided by:
Medtronic
Article History
Received: 16 September 2021
Accepted: 18 December 2021
First Online: 4 January 2022
Declarations
:
: Jan B. Pietzsch, Ph.D.: Dr. Pietzsch is the president, CEO, and a shareholder of Wing Tech Inc., an independent research firm conducting health economic analyses. Wing Tech Inc. received consulting fees from Medtronic, Inc. to conduct the analyses underlying this study. Benjamin P. Geisler, M.D., M.P.H.: Dr. Geisler is a senior consultant for Wing Tech Inc., an independent research firm conducting health economic analyses. Wing Tech Inc. received consulting fees from Medtronic, Inc. to conduct the analyses underlying this study. Annabelle R. Iken, M.Sc.: Mrs. Iken is a research associate for Wing Tech Inc., an independent research firm conducting health economic analyses. Wing Tech Inc. received consulting fees from Medtronic, Inc. to conduct the analyses underlying this study. Iris van Wijck, BSc: No conflict of interest. Suzanne Holewijn, MSc, PhD: No conflict of interest. Michel M. P. J. Reijnen, MD, PhD: Dr. Reijnen received consulting fees and research funding from Medtronic, Inc.